Tuesday, February 18, 2025

A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes

New research shows sotagliflozin is the only drug in its class to demonstrate these results.

from Top Health News -- ScienceDaily https://ift.tt/RxP8ynb

No comments:

Post a Comment

He survived 48 hours without lungs and lived

A critically ill 33-year-old man survived an almost unimaginable scenario—living for 48 hours without lungs—thanks to a groundbreaking surgi...